Chalfont St Giles, UK – 2 February 2011 – GE Healthcare Life Sciences today announced the winners of 2011 IN Cell Analyzer Image Competition. Geoffrey Grandjean from the United States, Marie Neguembor from Italy, and Lesley Caron from Australia, each took first place in a regional category. The winning images will be displayed on NBC Universal’s high-definition screen in Times Square, New York at a special event held April 20-22 2012.
More than 8,000 votes were cast on 30 shortlisted entries, all of which were acquired using an IN Cell Analyzer system. Finalists’ images included stained rat neurons, HeLa cells and human ovarian cancer cells, used in a wide range of applications such as toxicology screening and research into the molecular mechanisms underlying cancer and neuronal diseases.
The full details of the winners are;
1st place Americas
Geoffrey Grandjean, MD Anderson Cancer Center, US
Cancer therapeutic target identification
1st place Europe
Marie Neguembor, ALEMBIC, San Raffaele Scientific Institute, Italy
Molecular Biology - Cell differentiation studies
1st Asia/Rest of World
Leslie Caron, Genea, Australia
Inheritable muscle disease research
Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said “Every year we receive entries which are visually stunning and artistic but, importantly, also feature data generated at the forefront of research and development. This competition showcases both the cellular imaging capabilities of the IN Cell Analyzer systems and the inherent beauty of science.”
This year’s shortlist was selected by a panel of judges comprised of Dr. Kristie Nybo, Assistant Editor at BioTechniques, Dr. Nick Thomas, Principal Scientist at GE Healthcare and former Image Competition winner Carmen Laethem of Aerie Pharmaceuticals.
The images from the 2011 IN Cell Analyzer Competition can be seen here and will be available in a limited edition calendar and screen saver, both free* by registering at; https://promo.gelifesciences.com/EU/K11073/reg2.asp
*Offer available to eligible registrants unless prohibited by applicable local law, regulations or General Electric’s internal policies or rules relating to governments and healthcare professionals.
About the 2011 IN Cell Analyzer Image Competition
The IN Cell Image Competition, supported by BioTechniques, celebrates the outstanding research enabled by the superior image quality that IN Cell Analyzer systems deliver. Voting started on 7 November and continued online until 14 December. Attendees at two conferences (ASCB, December 3-7, USA and MBSJ, December 13-16, Japan) were also able to vote for their favourite. The votes were combined to select 3 winners, one from each region (Americas, Europe, Asia/Rest of World). Details of the judging panel can be found here and full terms and conditions can be found here. To view images from past winners, go to www.gelifesciences.com/incellcompetition
About GE Healthcare’s IN Cell Analyzer system
IN Cell Analyzer automated high content cell imagers, IN Cell Investigator image analysis software and IN Cell Miner data management software combine to provide a system that represents a total solution for high content sub cellular analysis in research and drug discovery. High-performance hardware, powerful software, and expert instrument and applications support are harmonized to transform the cellular workflow.
IN Cell Analyzer 2000 is a highly flexible, widefield high-content imaging instrument impressively enabling for a wide range of assays and techniques with the performance to meet your HCA needs, every day. The latest addition to the IN Cell Analyzer family, IN Cell Analyzer 6000 is a high-end, laser based confocal imaging platform for the most demanding high-content assays and screens that require exceptional sensitivity or that have an absolute need for confocality. Featuring a novel and proprietary optical system that incorporates an iris-like variable aperture design and next-generation sCMOS technology, IN Cell Analyzer 6000 maximises speed, sensitivity and image quality for challenging and variable assays.
For more detailed information visit www.gelifesciences.com/incell
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
For our latest news and high resolution images, please visit http://newsroom.gehealthcare.com
Media Contacts:
College Hill for GE Healthcare
Tim Watson, Dimithri Wignarajah
T: +44 (0)207 866 7858
E: GE-INCell@collegehill.com
